Benign mimics of prostatic adenocarcinoma

被引:15
|
作者
Trpkov, Kiril [1 ,2 ]
机构
[1] Univ Calgary, Calgary Lab Serv, Dept Pathol & Lab Med, 7007 14 St, Calgary, AB T2V 1P9, Canada
[2] Univ Calgary, Rockyview Gen Hosp, 7007 14 St, Calgary, AB T2V 1P9, Canada
关键词
ATYPICAL ADENOMATOUS HYPERPLASIA; METHYLACYL-COA RACEMASE; BASAL-CELL HYPERPLASIA; ISUP CONSENSUS CONFERENCE; NEEDLE-BIOPSY CORES; NEPHROGENIC ADENOMA; SCLEROSING ADENOSIS; HISTOLOGIC FEATURES; PARTIAL ATROPHY; GRANULOMATOUS PROSTATITIS;
D O I
10.1038/modpathol.2017.136
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Benign mimics present either as common challenges in daily routine practice or may cause diagnostic dilemmas because some are less commonly seen and one may be less familiar in recognizing them. There are a multitude of mimics of prostatic adenocarcinoma, which may represent normal gland structures, benign proliferations, atrophic lesions, hyperplastic or metaplastic changes, and inflammatory processes. Some of them are preferentially found in certain anatomic areas of the prostate, either confined to the prostate, or outside of the gland. Various benign mimics of prostatic carcinoma may be also evaluated based on their morphologic similarity to Gleason patterns 3-5 of prostatic adenocarcinoma. Most of the mimics are easily recognizable in larger specimens, such as TUR of the prostate or radical prostatectomy specimens, but they may pose diagnostic problems when the evaluation is done on limited tissue, such as needle-core biopsies or if prostate specimens are infrequently encountered in practice. Therefore, before signing out a report with a diagnosis of prostatic carcinoma, pathologists should carefully consider and rule out the various benign lesions that may mimic carcinoma. This is particularly relevant in the current prostate biopsy practice which relies on using extended biopsy core templates. The awareness and familiarity with the characteristic features of the mimics and judicial use of additional ancillary tests, including immunohistochemistry can prevent overdiagnosis and false-positive interpretation. This review provides a contemporary update on the broad spectrum of the benign prostatic lesions that can mimic prostate adenocarcinoma, outlines their key morphologic and immunohistochemical diagnostic features, and provides a diagnostic, pattern-based approach in establishing a correct diagnosis and distinguishing them reliably from prostatic adenocarcinoma.
引用
收藏
页码:S22 / S46
页数:25
相关论文
共 50 条
  • [21] Chondroitin sulphate and mast cell alterations in benign prostatic hyperplasia (BPH) and prostatic adenocarcinoma (PCA)
    Magkou, C
    Koukoumides, C
    Sitaras, NM
    TISSUE ANTIGENS, 2004, 64 (04): : 385 - 385
  • [22] MATRIX METALLOPROTEINASE-9 EXPRESSION IN PRIMARY HUMAN PROSTATIC ADENOCARCINOMA AND BENIGN PROSTATIC HYPERPLASIA
    HAMDY, FC
    FADLON, EJ
    COTTAM, D
    LAWRY, J
    THURRELL, W
    SILCOCKS, PB
    ANDERSON, JB
    WILLIAMS, JL
    REES, RC
    BRITISH JOURNAL OF CANCER, 1994, 69 (01) : 177 - 182
  • [23] Protein C Inhibitor as a Diagnostic Marker: Immunohistochemical Expression in Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia
    Selmani, Liridon
    Limani, Rine
    Agahi, Riaz
    Hoxha, Ilir
    Kerliu, Suzana Manxhuka
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2024, 14 (03)
  • [24] Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia
    Lee, LM
    Pan, CC
    Cheng, CJ
    Chi, CW
    Liu, TY
    ANTICANCER RESEARCH, 2001, 21 (2B) : 1291 - 1294
  • [25] PHYSICAL AND CHEMICAL DETERMINATIONS OF PROSTATIC SECRETION IN BENIGN HYPERPLASIA, PROSTATITIS, AND ADENOCARCINOMA
    ANDERSON, RU
    FAIR, WR
    INVESTIGATIVE UROLOGY, 1976, 14 (02): : 137 - 140
  • [26] APRIN/AS3 immunohistochemical expression and promoter methylation in prostatic adenocarcinoma, prostatic intraepithelial neoplasia and benign prostatic tissue
    Klepper, S.
    Denes, V.
    Carpinto, G.
    Makarowskiy, A.
    Geck, P.
    Pilichowska, M.
    MODERN PATHOLOGY, 2007, 20 : 156A - 156A
  • [27] APRIN/AS3 immunohistochemical expression and promoter methylation in prostatic adenocarcinoma, prostatic intraepithelial neoplasia and benign prostatic tissue
    Klepper, S.
    Denes, V.
    Carpinito, G.
    Makarowskiy, A.
    Geck, P.
    Pilichowska, M.
    LABORATORY INVESTIGATION, 2007, 87 : 156A - 156A
  • [28] Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma
    Hussein, Mahmoud-Rezk A.
    Al-Assiri, Mana
    Musalam, Adel O.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2009, 86 (02) : 108 - 113
  • [29] Nuclear expression of phospho-Akt in prostatic adenocarcinoma, prostatic intraepithelial neoplasia and benign nodular hyperplasia
    Richmond, J
    Trotman, W
    Philips, G
    Trainer, T
    MODERN PATHOLOGY, 2005, 18 : 161A - 161A
  • [30] Nuclear expression of phospho-Akt in prostatic adenocarcinoma, prostatic intraepithelial neoplasia and benign nodular hyperplasia
    Richmond, J
    Trotman, W
    Philips, G
    Trainer, T
    LABORATORY INVESTIGATION, 2005, 85 : 161A - 161A